Position in REGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,341,550
-$779,711 QoQ
Shares Held
5,359
+0.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#438
of 1,322 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Oxbow Advisors, LLC holds $8,176,129 across 2 Biotechnology names. REGN ranks #2 (40.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
86,224 | $4,834,579 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
5,359 | $3,341,550 |
All Filings in REGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,341,550 | 5,359 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $4,121,261 | 5,334 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $4,111,751 | 5,327 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $2,950,230 | 5,247 | Shares | Sole | 2025-10-31 | |
| 2025-03-31 | $2,316,842 | 3,653 | Shares | Sole | 2025-05-01 | |
| No filing history on record for this holder in this stock. | ||||||